Does RESLIZUMAB Cause Condition aggravated? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Condition aggravated have been filed in association with RESLIZUMAB (CINQAIR). This represents 1.0% of all adverse event reports for RESLIZUMAB.
6
Reports of Condition aggravated with RESLIZUMAB
1.0%
of all RESLIZUMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Condition aggravated From RESLIZUMAB?
Of the 6 reports.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RESLIZUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does RESLIZUMAB Cause?
Dyspnoea (86)
Asthma (82)
Drug ineffective (80)
Incorrect dose administered (63)
Hypertension (47)
Headache (41)
Wheezing (40)
Cough (36)
Oropharyngeal pain (31)
Fatigue (29)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which RESLIZUMAB Alternatives Have Lower Condition aggravated Risk?
RESLIZUMAB vs RESMETIROM
RESLIZUMAB vs RESTASIS
RESLIZUMAB vs RETINOL
RESLIZUMAB vs REVATIO
RESLIZUMAB vs REVEFENACIN